Keyphrases
Paclitaxel
100%
Carboplatin
100%
Advanced Ovarian Cancer
100%
Neuropathy
75%
Neutropenia
50%
3-cycle
50%
Epithelial Ovarian Carcinoma
50%
Phase II Study
50%
Chemotherapy
25%
Initial Treatment
25%
Median Survival
25%
Area under the Curve
25%
Stage III-IV
25%
Epithelial Ovarian Cancer
25%
Alopecia
25%
Overall Response Rate
25%
Postoperative Adjuvant Chemotherapy
25%
Neoadjuvant Chemotherapy
25%
Hematotoxicity
25%
Cytoreductive Surgery
25%
Median Progression-free Survival
25%
Tubal Carcinoma
25%
Primary Peritoneal Cancer
25%
Epoetin Alfa
25%
Complete Response Rate
25%
Stage IC
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Ovary Carcinoma
100%
Paclitaxel
100%
Carboplatin
100%
Neuropathy
75%
Neutropenia
50%
Progression Free Survival
25%
Carcinoma
25%
Recombinant Erythropoietin
25%
Alopecia
25%
Diseases
25%
Medicine and Dentistry
Krukenberg Tumor
100%
Paclitaxel
100%
Carboplatin
100%
Neuropathy
75%
Neutropenia
50%
Carcinoma
25%
Progression Free Survival
25%
Adjuvant Chemotherapy
25%
Recombinant Erythropoietin
25%
Alopecia Mucinosa
25%
Neoadjuvant Chemotherapy
25%
Cytoreductive Surgery
25%
Diseases
25%